Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

Cheol-Hyung Lee ,  Yun Bin Lee ,  Minseok Albe 외 11명

Clinical and Molecular Hepatology

2020 .01

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence

강성희 ,  조혜기 ,  조은주 외 7명

Journal of Korean Medical Science

2018 .01

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma

Sojung Han ,  Do Young Kim

Clinical and Molecular Hepatology

2020 .01

Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

박정길

Clinical and Molecular Hepatology

2015 .01

Effects of the mixed formulation of sorafenib and blue honeysuckle on the pharmacokinetics profiles of sorafenib

강현구 ,  강수진 ,  구세광 외 2명

대한예방한의학회지

2019 .01

Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure

Jaewoong Kim ,  Jin Won Chang ,  박준용

Journal of Liver Cancer

2020 .01

Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation

Minjeong Kim ,  Jinsoo Rhu ,  Gyu-Seong Choi 외 2명

Annals of Surgical Treatment and Research

2021 .07

Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib

Dongxu Kang ,  최혜진 ,  Zhezhu Han 외 3명

Yonsei Medical Journal

2017 .01

Usefulness of sarcopenia in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment

Min-Su PARK ,  Bum-Soo KIM ,  Sang-Mok LEE

대한외과학회 학술대회 초록집

2019 .10

Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment

김보현 ,  박중원

Journal of Liver Cancer

2021 .09

Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation

Jinsoo RHU ,  Jae-Won JOH ,  Gyu-Seong CHOI 외 1명

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .12

Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation

Jinsoo Rhu ,  Gyu-Seong Choi

대한임상종양학회 학술대회지

2022 .02

Absence of antitumor effects of metformin in sorafenib-treated patients with hepatocellular carcinoma recurrence after hepatic resection and liver transplantation

Yong-Kyu Chung ,  Shin Hwang ,  Gi-Won Song 외 10명

Annals of Hepato-Biliary-Pancreatic Surgery

2018 .11

Tumor lysis syndrome following sorafenib treatment in hepatocellular carcinoma

Kim ,  Shin Young ,  Kim 외 7명

영남의대학술지

2015 .01

An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenib

Dong-Hwan Jung ,  Shin Hwang ,  Gi-Won Song 외 4명

Annals of Hepato-Biliary-Pancreatic Surgery

2015 .02

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?

Jong Man Kim

Clinical and Molecular Hepatology

2021 .10

Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data

김도영 ,  김혜진 ,  한광협 외 13명

Cancer Research and Treatment

2016 .01

A Case of Nivolumab-Induced Lichen Planus

오세진 ,  최영환 ,  변현정 외 6명

Annals of Dermatology

2019 .01

A Case of Achieving Partial Remission with the Combination of Sorafenib and Nivolumab in a Patient with Hepatocellular Carcinoma Showing Disease Progression after Nivolumab Therapy

Sang Youn Hwang

Journal of Liver Cancer

2019 .01

Recipient liver splitting to facilitate piggyback hepatectomy in adult living donor liver transplantation

Kim Sung-Min ,  Hwang Shin ,  Moon Deok-Bog 외 1명

Clinical Transplantation and Research

2021 .01